Details

Autor(en) / Beteiligte

• Ledermann, Jonathan A
• Luvero, Daniela
• Shafer, Aaron
• O’Connor, Dennis
• Mangili, Giorgia
• Friedlander, Michael
• Pfisterer, Jacobus
• Mirza, Mansoor R
• Kim, Jae-Weon
• Alexandre, Jerome
• Oza, Amit
• Brown, Jubilee

Titel

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mucinous Ovarian Carcinoma

Ist Teil von

• International journal of gynecological cancer, 2014-11, Vol.24 (9 Suppl 3), p.S14-S19

Ort / Verlag

England: by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology

Erscheinungsjahr

2014

Quelle

MEDLINE

Beschreibungen/Notizen

• ABSTRACTMucinous carcinomas of the ovary can be primary or metastatic in origin. Improvements in the pathological diagnosis have increased the ability to distinguish between primary and metastatic ovarian cancers and shown that primary mucinous carcinomas are a rare subtype of ovarian cancer. Most tumors are diagnosed at an early stage, and the prognosis after surgery is good. Advanced or recurrent mucinous carcinoma of the ovary responds poorly to current cytotoxic treatments, and the prognosis is poor. Here, we review the guidelines for surgery and the results of treatment of advanced and recurrent disease. Chemotherapy with platinum and paclitaxel is currently used to treat advanced disease, but the effect of these drugs is modest, and new treatments are needed.